Finn's Take· TL;DRA 63-year-old Norwegian man has achieved what doctors are calling an extraordinary medical breakthrough—a cure for HIV after receiving a stem cell transplant from his brother . What makes this case particularly remarkable isn't just the successful outcome, but the incredible stroke of luck that made it possible.
The Oslo patient, as doctors have dubbed him, was first diagnosed with HIV in 2006 at age 44, and later developed myelodysplastic syndrome, a fatal blood cancer, in 2017 . His medical team initially searched for a donor with a specific genetic mutation that blocks HIV, but when they couldn't find one, they turned to his elder brother as a compatible match .
On the day of the procedure in November 2020, doctors made an unexpected discovery: the brother carried not one, but two copies of the rare CCR5Δ32 mutation . As the patient himself put it, "it was like winning the lottery twice" .
The CCR5Δ32 mutation removes the CCR5 receptor on white blood cells that HIV normally uses as its entry point, effectively making the immune system impervious to HIV's tricks . Only around 1% of people in northern Europe carry this protective mutation , making the brother's genetic profile exceptionally rare.
The bone marrow transplant involved infusing healthy, blood-making stem cells into the patient's body to replace diseased ones, ultimately remodeling his entire blood supply and immune system . Although the patient experienced graft-versus-host disease, a severe reaction where transplanted cells attack the recipient's body, this immune response may have actually helped eliminate HIV from his system .
Two years after the transplant, doctors took the bold step of stopping his antiretroviral medications, and found no trace of the virus in samples from his blood, gut, and bone marrow . As lead researcher Dr. Anders Eivind Myhre stated, "For all practical purposes, we are quite certain that he is cured" .
This marks only the tenth case worldwide of HIV cure through stem cell transplantation, and the first to involve a family donor . Previous cases include the original Berlin patient Timothy Ray Brown in 2008, followed by patients in London, New York, Geneva, and Düsseldorf .
However, these transplants remain extremely risky procedures that leave patients vulnerable to infection, with 10-20 percent of recipients dying within a year . The painful and potentially dangerous procedure is reserved for people who have both HIV and deadly blood cancer, making it unfeasible for the millions living with HIV worldwide .
Today, the Oslo patient is "having a great time" and has more energy than he knows what to do with . Given his robust health, researchers suggest his nickname may no longer be appropriate: "The Oslo patient is perhaps no longer a patient. At least he doesn't feel like it" .
While this treatment cannot be scaled to help all HIV patients, researchers believe studying these rare cases will reveal crucial insights about how HIV works, potentially leading to broader cure strategies . What makes this case particularly significant is that extensive testing showed the gut was completely clear of functioning HIV DNA—the virus's preferred hiding spot where it typically lurks in dormant states .
Scientists are now working to compare all existing HIV cure cases to identify the most effective combination of biomarkers, with plans for coordinated research using standardized protocols . Each case brings researchers closer to understanding the complex puzzle of HIV elimination, offering hope that future treatments might one day make such miraculous family donations unnecessary.